GSK is hosting a webinar on June 13, 2023, on “Respiratory Syncytial Virus (RSV) disease burden and option for vaccine” and will be hosted by Dr. Cendric “Jamie” Rutland, MD. There they will discuss:
- RSV disease burden and the unmet need in older adults
- Introduction to AREXVY, a vaccine to prevent RSV-LRTD in individuals 60 years of age and older
- Key data from the clinical trial for AREXVY
- Live Q&A with Dr. Rutland
AREXVY is indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in individuals 60 years of age or older.
Click HERE to register